Skandigen Interim report January - March 1996

Skandigen Interim report January - March 1996 - The Group's sales amounted to MSEK 7.8 (0) for the three months. The consolidated result after depreciation was MSEK 0 (-4.9). The result after net financial items amounted to MSEK 10.4 (-5.0). The net financial items include a non-recurring revenue from sale of subscription warrants of MSEK 10.2 (0). - The part-owned company SIBIA Neurosciences, Inc. has in March filed an S-1 Registration Statement with the Securities and Exchange Commission for an initial public offering of shares with a listing on NASDAQ. ------------------------------------------------------------ This information was brought to you by Waymaker http://www.waymaker.net